TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,419,000 | +15.9% | 107,367 | -0.6% | 0.25% | +11.2% |
| Q2 2016 | $1,224,000 | -4.0% | 107,967 | -1.3% | 0.22% | -5.9% |
| Q1 2016 | $1,275,000 | -0.2% | 109,367 | +0.6% | 0.24% | -0.8% |
| Q4 2015 | $1,278,000 | -66.5% | 108,692 | -48.6% | 0.24% | -63.1% |
| Q2 2015 | $3,819,000 | +11.0% | 211,486 | +18.4% | 0.65% | +3.8% |
| Q1 2015 | $3,439,000 | +45.6% | 178,642 | +32.4% | 0.63% | +47.2% |
| Q4 2014 | $2,362,000 | -27.9% | 134,892 | -24.8% | 0.43% | -31.2% |
| Q3 2014 | $3,276,000 | -22.3% | 179,292 | -2.1% | 0.62% | -16.6% |
| Q2 2014 | $4,217,000 | -0.2% | 183,092 | +5.0% | 0.74% | -5.8% |
| Q1 2014 | $4,226,000 | +168.5% | 174,392 | +178.5% | 0.79% | +161.8% |
| Q4 2013 | $1,574,000 | – | 62,612 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |